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Abstract:  
Wilms’ tumour 1 (WT1) is essential for development and homeostasis of multiple 
mesodermal tissues. Despite evidence for post transcriptional roles, no endogenous WT1 
target RNAs exist. Using RNA immunoprecipitation and UV-crosslinking, we show WT1 
binds preferentially to 3’ UTRs of developmental targets. These target mRNAs are 
downregulated upon WT1 depletion in cell culture and developing kidney mesenchyme. Wt1 
deletion leads to rapid turnover of specific mRNAs. WT1 regulates reporter gene expression 
through interaction with 3’ UTR binding sites. Combining, experimental and computational 
analyses, we propose that WT1 influences key developmental and disease processes in part 
through regulating mRNA turnover.  
KEYWORDS:  WT1, FLASH, 3’ UTR, Hybrids, RNA secondary structures, Developmental 
pathways 
Running Title: WT1 interacts with 3’UTR of developmental targets 
 
Introduction 
The different steps in gene expression, from transcription through a series of post 
transcriptional events, are closely interconnected and some multifunctional proteins regulate 
several points in this pathway. One potential example is the Wilms' tumour gene, WT1. Mice 
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lacking Wt1 die at mid-gestation, through defective coronary vasculature, suffer from 
congenital diaphragmatic hernia, have no kidneys, gonads, spleen or adrenals. All these 
defects can be traced to a key role for WT1 in the development of tissues derived from the 
intermediate and lateral plate mesoderm. In humans, germ line WT1 mutations lead to the 
eponymous pediatric cancer, genitourinary anomalies and in some cases congenital 
diaphragmatic hernia and heart disease (Chau and Hastie 2012). 
Furthermore, WT1 is a key regulator of the balance between mesenchymal and epithelial 
states in these tissues, being required for the mesenchyme to epithelial transition (MET), a 
key step in nephron formation, and for the epithelial to mesenchyme transition (EMT) that 
produces coronary vascular progenitors from the epicardium. WT1 also plays essential roles 
in adult tissue homeostasis. Hence ubiquitous deletion of Wt1 in adult mice leads to acute 
kidney glomerulosclerosis, atrophy of the exocrine pancreas and spleen and widespread 
reduction in bone and fat (Chau et al. 2011). A recent study showed that WT1 is reactivated 
during tissue repair and during adult tumorigenesis where it is required in the mesenchymal 
component and vasculature for tumour growth (Wagner et al. 2014).  
The molecular mechanisms by which WT1 fulfils these apparently diverse roles have been 
attributed to its transcriptional function.  Accordingly, there is substantial evidence that WT1 
binds genomic DNA and regulates transcription, acting either as an activator or repressor 
(Essafi et al. 2011; Toska and Roberts 2014). A growing number of physiological WT1 
transcriptional targets have been identified in development, homeostasis and disease 
(Motamedi et al. 2014; Kann et al. 2015; Dong et al. 2015). However, the evidence 
suggests that transcriptional regulation is not the only WT1 function.  
The two major essential isoforms (Barbaux et al. 1997; Hammes et al. 2001) conserved 
throughout vertebrate evolution are created by an alternative splice that inserts three amino 
acids (lysine-threonine-serine; KTS) between the third and fourth zinc finger (Hastie 2001). 
The first suggestion that WT1 may function post-transcriptionally came from Larsson et al. 
1995, showing that the + KTS isoforms associate with splicing factors. WT1 was then shown 
to integrate into active splice complexes by interacting with the splicing factor U2AF65 
(Davies et al. 1998). Moreover, WT1 binds both RNA and DNA with similar binding 
efficiencies as demonstrated by structural and kinetic studies (Bardeesy and Pelletier 1998; 
Caricasole et al. 1996; Zhai et al. 2001). Structural modelling studies also identified an 
RNA recognition motif (RRM) in WT1 (Kennedy et al. 1996). Further support for 
posttranscriptional roles for WT1 was provided by Niksic et al. 2004, showing that all 
isoforms shuttle between  nucleus and cytoplasm where they are located on actively 
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translating ribosomes. In particular, the +KTS isoforms were shown to recruit transcripts 
containing a viral RNA sequence to polysomes, regulating their translation (Bor et al. 2006). 
A considerable amount of data therefore supports roles for WT1 from splicing through to 
translation. However, causal evidence for direct WT1 functions in specific steps, and 
understanding of the mechanisms involved, have been limited by the absence of characterized 
endogenous WT1 RNA targets. To address this, we identified WT1 interacting RNAs in 
mouse ES cells and a mesonephric cell line by a combination of RNA-immunoprecipitation 
and sequencing (RIP-seq) and a modification of the CLASH UV-crosslinking technique 
(Helwak et al. 2013) termed FLASH. The latter identifies RNAs that directly interact with 
WT1 as well as RNA-RNA duplexes formed by these target RNAs. The interaction of 
intramolecular RNA hybrids is increased in the presence of WT1. This study provides strong 
evidence that the tumour suppressor protein, WT1 regulates physiologically important RNAs 
and their stability through interactions with 3’ untranslated regions (3' UTRs). 
 
Results and Discussion: 
WT1 binds to multiple categories of RNA 
RNA IP (RIP, Bharathavikru and Dudnakova 2016) was performed on ES cells and 
mesonephric M15 cells along with negative control RIP to identify RNAs that interact with 
endogenous WT1. The specificity of the antibody was verified by immuno- pulldown and 
western blotting (Supplemental Fig. S1A). Recovered RNAs were identified by RT PCR and 
Illumina sequencing. Overall numbers of reads obtained are presented in Supplemental Fig. 
S1B. Reads were mapped to the mouse genome and analyzed for different RNA categories 
(Fig. 1A). RIP data were processed to identify regions where the number of uniquely aligned 
reads passed statistical significance (FDR<0.05; minimum of 5 reads), and overlapping 
regions of aligned reads were clustered (minimum of 5 reads) using the pyCRAC software 
(Webb et al. 2014). The RNA biotypes of these clusters were determined using Ensembl 
annotations. Strikingly, WT1 targets were predominantly (96%) identified as protein coding 
mRNAs (Fig. 1A). Amongst ncRNA targets, the majority were long intergenic noncoding 
(linc) RNAs followed by microRNAs (miRNAs) and small nucleolar RNAs (snoRNAs). 
Closer examination of the position on protein-coding genes of significant clusters revealed 
higher recovery of sequences at the 5’ and 3’ end of transcripts and the UTRs (Fig. 1B). A 
number of transcripts had notably high read coverage including those for Igfbp5, shown as an 
example in Fig. 1C.  
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To confirm the sequence data, RIP reactions were performed followed by PCR across 
different regions of selected protein-coding transcripts (Fig. 1D and Supplemental Fig. 
S1C). For most of the selected targets including Igfbp5 the results were in good agreement 
with the RIP-seq analysis, showing significant enrichment towards the 3’ UTR. In order to 
assess the functional relevance of the WT1 interacting RNA, a gene ontology analysis was 
performed. Several developmental pathways that are regulated by WT1 were identified as 
significant GO categories in this analysis, including coronary vasculature development and 
wnt signaling pathway (Supplemental Fig. S1D and S1E, Supplemental Tables S1 and 
S2).   
UV crosslinking confirms WT1 enrichment over the 3’ UTR of mRNAs 
To identify specific protein-RNA interaction sites, we adopted a UV cross-linking approach. 
Since ncRNAs were identified among WT1 interacting RNA (Fig. 1A), we applied an 
experimental strategy that can identify RNA-RNA interactions. The crosslinking and 
sequencing of hybrids (CLASH) technique can identify both RNA-protein and RNA-RNA 
interactions, but requires the use of epitope-tagged “bait” proteins (Helwak et al. 2013). We 
developed a modified technique, formaldehyde-assisted crosslinking and sequencing of 
hybrids (FLASH) (Fig. 2A). This allowed the antibody-based IP of endogenous WT1 and 
recovery of crosslinked RNAs in the M15 cell line.  
Reads obtained from FLASH experiments were analyzed separately for protein-RNA 
interactions and for protein associated RNA-RNA hybrids (Webb et al. 2014; Travis et al. 
2014). The assignment of significant clusters to biotypes showed that the major category of 
interacting RNA was protein coding transcripts (Fig. 2B), consistent with the RIP-seq data. 
The most enriched ncRNAs. were snoRNAs (different from RIP-seq due to the difference in 
methodology), followed by similar numbers of miRNAs and lincRNAs. On mRNAs, WT1 
binding sites showed strong enrichment over the 3’ end of the ORFs and 3’ UTRs (Fig. 2C), 
in comparison to input and control IgG FLASH (Supplemental Fig. S2). GO analysis of the 
terms associated with the WT1 interacting RNAs (Supplemental Table S3) showed 
enrichment for developmental pathways, cell adhesion and cell migration, similar to the RIP-
seq data. A gene ontology chart generated by REVIGO is shown in Fig. 2D. Thus, WT1 was 
found to interact with developmental regulators, as identified by both RIP-seq and FLASH.  
 
WT1 associates with RNA at the 3’ UTR through secondary structures  
The FLASH analysis includes ligation steps that can lead to the formation of hybrid cDNAs 
derived from two independent RNA molecules (intermolecular), or from non-contiguous 
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sequences of the same RNA (intramolecular/gene-self). To investigate whether WT1 interacts 
with secondary structured RNA or other RNA duplexes, we analyzed the WT1 FLASH data 
for chimeric reads derived from RNA hybrids using the hyb software pipeline (Travis et al. 
2014). In the FLASH data, 0.49% of reads were identified as hybrids, consistent with 
recovery in previous analyses. The control input data for the WT1 RIP was similarly 
analyzed which showed 0.03% hybrids.  
A representation of the different hybrids obtained in WT1 FLASH is shown in Fig. 3A. The 
different datasets of WT1 interacting RNA show a reasonable overlap (60% of the protein-
coding genes identified by FLASH were also found by RIP-Seq; Supplemental Table S4). 
Interactions recovered within 3’ UTR sequences were most frequently intramolecular, 
comprising 52% of hybrids. Intermolecular interactions between mRNAs and microRNAs 
(miRNAs) were ~10-fold less frequent, comprising 5% of hybrids with 964 unique 
interactions. Notably, in human AGO1 data mRNA-miRNA interactions were 3-fold more 
numerous than intramolecular interactions within 3’ UTRs (Helwak et al. 2013). In addition, 
the mean energy of intermolecular 3’UTR base-pairing was -15.1 kcal/mol in the FLASH 
data, significantly less than in the control -7.3 kcal/mol  (p<2.2e-16 by Wilcoxon rank sum 
test) (Fig. 3A, Supplemental Fig. S3A and S3B). Several interactions were between non-
contiguous sequences that were sufficiently close to allow folding prediction for the RNA to 
assess their stability. Representative examples of local contacts (Fig. 3B) and those with 
extended secondary structures are shown in Fig. 3C. These structures have lower 
hybridization energy indicating a more stable structure.  
During the preparation of this manuscript, RNA-RNA interactions using psoralen crosslinking 
were identified. We compared the RNA hybrids identified by Psoralen Analysis of RNA 
Interactions (PARIS) (Lu et al. 2016) to the RNA hybrids identified by WT1 FLASH. Analysis 
of WT1 interacting Podxl, Igfbp3, Upk3b, Ctdsp2, revealed a difference in the location and 
energy of the hybrids and the strength of the hybrids (Fig. 3D, Supplemental Fig. S3C). Thus, 
in the presence of WT1 there is an increase in the number of stable intramolecular RNA 
interactions, supporting a role for WT1 as a nucleating centre for these interactions. Recent 
studies with the double-stranded RNA binding protein, Staufen (Sugimoto et al. 2015) show 
secondary RNA structures to be common and functionally important for gene expression. WT1 
interaction at the 3’ UTR of targets also show secondary structures suggesting a role in 
regulating RNA stability. To assess the potential of the predicted, WT1-bound, RNA structures, 
we analyzed the hybrid sequences for the presence of any miRNA binding sites. A significant 
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proportion of hybrids were found to harbor clusters of miRNA binding sites (Supplemental 
Fig. S3D, Supplemental Table S5).  
Since its identification as an RNA binding protein, it has been speculated that WT1 
associated RNA binding may not be exclusively determined by sequence. This was indeed 
shown with WT1 Zinc fingers (Zf) and RNA aptamers cloned based on the SELEX motifs, 
which showed that WT1 Zf-RNA interaction was not just sequence dependent but also 
required a hairpin loop structure adjacent to the consensus motif (Zhai et al. 2001).This is in 
agreement with our hybrids analysis, which shows that WT1 interacts with stable RNA 
secondary structures. The exact contribution of sequence and structural requirements for the 
interaction require further investigation. 
 
WT1 regulates the expression of a subset of the RNA binding targets  
As the WT1 RNA interaction data support a role in RNA stability, we assessed whether the 
expression levels of these targets were also regulated by WT1. The results by cuffdiff 
analysis (Trapnell et al. 2012) are summarized in Fig. 4A. Of the differentially expressed 
genes in ES cells on Wt1 KO (using an adjusted p value of 0.05 and with fragments per 
kilobase of transcript per million mapped reads (FPKM) 1 in at least one condition), 92 
genes were upregulated and 67 downregulated. In M15, 156 genes were differentially 
expressed on Wt1 knockdown (also see Supplemental Fig. S4), with 50 genes upregulated 
and 106 downregulated.  
In M15 cells, 40% and 26% of differentially regulated genes were identified by RIP-seq and 
FLASH respectively. In ES cells, 26% of differentially regulated genes were identified as 
interacting with WT1 by RIP-seq.  45 of the differentially regulated genes in M15 cells, were 
found to have 267 gene- self hybrids from the FLASH analysis. Importantly, 252 of these 
hybrids were associated with downregulated genes and very few of the WT1 interacting 
RNAs (6%) were upregulated. GO enrichment analysis of genes differentially regulated in 
both ES and M15 cells upon downregulation of Wt1 showed enrichment for pathways such as 
cell adhesion, positive regulation of developmental processes, wnt signaling, cell 
proliferation, skeletal system development and urogenital system development (Fig. 4B, 
Supplemental Tables S6 and S7). These processes are all disrupted through Wt1 mutation or 
loss but the mechanistic details have remained incomplete (Chau and Hastie 2012).   
The expression changes found in the RNA-seq data were validated by qRT-PCR in both ES 
cells and M15 cells for representative genes, associated with the most significant GO terms. 
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This analysis confirmed the downregulation of the following RNA binding targets with 
significant p values. These include Rspo1 and Wnt2b for wnt signalling; Cdh11 and Podxl for 
adhesion, Igfbps for IGF signalling and Gas1 for proliferation. Other targets that followed 
similar trend in both RNA-seq and qRT PCR include Wnt2b and the mesothelial marker 
Upk3b. WT1 has recently been shown to regulate a subset of mesothelial origin progenitors 
towards the fat lineage (Chau et al. 2014). Selected upregulated candidate genes including 
Mt2 and Hnf1b were also validated by qRT-PCR (Fig. 4C).  
In order to validate the findings in embryonic tissue, expression of selected target genes 
(Rspo1, Cdh11, Podxl and Gas1) was compared in FACS sorted wildtype versus Wt1 mutant 
metanephric mesenchyme from E13.5 kidney cells. These were obtained by crossing the Nes-
Cre and Wt1co alleles with a Wt1GFP knock-in model (Essafi et al. 2011). GFP+ cells from 
GFP control (Wt1co/GFP), GFP- cells from cre control (Nes-Cre Wt1co/+) and Wt1-deficient 
(Nes-Cre Wt1co/GFP) were compared for expression.  qRT-PCR analysis of the selected 
candidates showed up to 30 fold downregulation of expression  in the absence of Wt1 (Fig. 
4D), confirming the physiological relevance of these observations. 
 
The majority of WT1 dependent-RNA binding targets are not WT1 Transcriptional 
Targets  
WT1 is known to both activate and repress transcription (reviewed in Toska and Roberts 
2014). In contrast, the global RNA interactome analysis supports a role for WT1 as an RNA 
binding protein, functioning by interacting with the 3’ UTR of RNA and potentially 
regulating stability. Here, we have shown that a significant number of the WT1 interacting 
RNA targets are reduced upon Wt1 deletion/knockdown, reflecting WT1-mediated 
upregulation at transcriptional and/or post transcriptional steps.  
Consistent with post transcriptional effects of WT1, a correlation was observed between the 
ratios of coverage (proportion of the length of the 3’ UTR with reads mapped) and RPKM 
between RNA interaction and transcriptome changes (Fig. 5A and Supplemental Fig. S5A). 
Downregulated genes in ES have increased WT1 coverage and Reads per kilobase per 
million mapped reads (RPKM) ratios in comparison to unregulated genes (p < 2.2e-16 by 
Wilcoxon rank sum test) or upregulated genes (p < 8.2e-14 by Wilcoxon rank sum test).  
Similarly, recurrent kmers occurring in 3’ UTRs were identified in the single read FLASH data. 
The polyadenylation signal AATAAA had the highest Z score, and three similar sequences 
were also found in the top 10 kmers. However, on correlation with downregulation, TGTAAAT 
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motif was found by MEME (Bailey and Elkan, 1994) at 294 sites (e value 2.7e-562), which is 
different from the motif identified by RIP-seq (Supplemental Fig. S5B, S5C). 
To investigate whether downregulated, WT1 target mRNAs are also directly regulated by 
transcription, we compared them to published WT1 ChIP-seq data (Motamedi et al. 2014). 
On comparing the 156 differentially regulated genes from the M15 transcriptome analysis, to 
the published set of 1771 WT1 ChIPseq targets, there were 22 overlapping targets. Of the 38 
most downregulated and interacting RNA targets identified in our study, only 7 were present 
in the above transcriptional target dataset (Supplemental Table S8). A summary of the 
overlap between the RNA interacting candidates, differentially regulated targets and ChIP-
seq targets identified by the different analyses in relation to the transcriptome analysis is 
presented in Supplemental Fig. S5D.  
 
WT1 regulates RNA stability 
To test whether, as hypothesized, WT1 regulates the turnover of target RNAs, wildtype and 
Wt1 depleted cells were treated with actinomycin and RNA decay was measured using qPCR. 
As shown in Fig. 5B, both Podxl and Igfbp5 mRNAs decayed more rapidly in ES and M15 
cells when Wt1 is deleted or downregulated respectively.  To address whether WT1 is 
regulating gene expression through direct interactions with the 3’ UTR of mRNAs, fragments 
with WT1 binding sites were cloned into a luciferase reporter vector. Reduced luciferase 
activity was observed in Wt1 knockdown cells transfected with WT1 interacting 3’ UTR 
fragments in comparison to the controls (Fig. 5C). Moreover, in a destabilized GFP reporter 
system, a rapid loss in GFP expression was observed in Wt1 knockdown cells transfected 
with the Igfbp5 UTR fragment that has the WT1 binding region in comparison to the control 
transfections which showed no change in GFP expression. (Supplemental Fig. S5E). We 
conclude that direct WT1 binding to RNA enhances the levels of mRNA targets.  
In summary, we present several lines of evidence to support the conclusion that WT1 
regulates the stability of mRNAs through direct interactions. In addition to the direct 
experimental evidence, there are other considerations that support a role for WT1 in post 
transcriptional regulation. Our data shows that 94% of WT1 dependent interacting target 
RNAs were downregulated which deviates from the published WT1 transcriptional targets. 
Two studies have shown that 72% (Motamedi et al. 2014) and 77% (Dong et al. 2015) of 
WT1 dependent transcriptional targets are downregulated, reflecting the fact that WT1 
functions as a transcriptional activator or repressor. Consistent with this, only a small 
percentage of the downregulated WT1 interacting RNAs, overlap with the WT1 ChIPseq 
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targets (Supplemental Fig. S5D). Finally, the RNA binding motifs identified become 
significant on ranking based only on downregulated targets (Supplemental Fig. S5B, S5C). 
We propose that WT1 preferentially interacts with 3’ UTRs and that this interaction 
antagonizes binding of the degradation machinery either directly or via stabilization of the 
mRNA structure, potentially through secondary structures (Fig. 5D). Although, our analysis 
supports a role for WT1 in stabilizing RNAs, it does not exclude a role in promoting RNA 
turnover.   
This study has revealed a few WT1-dependent genes, Podxl (Palmer et al. 2001); Rspo1 
(Motamedi et al. 2014) which are both transcriptional and post transcriptional targets. 
Hence, for some genes, WT1 may chaperone them through various steps of the regulatory 
cascade. However, there is little overlap between the WT1 dependent target RNAs and WT1 
transcriptional targets, emphasizing the key role of post transcriptional processes in tissue 
development and homeostasis. The disparity in the number of WT1 interacting RNA and 
WT1 regulated RNAs may imply a role for WT1 in other post transcriptional processes 
including mRNA localization and translation. Recent genetic evidence linking Wilms’ tumor 
(WT) susceptibility with mutations in an exosome component (Astuti et al. 2012) and the 
microRNA processing genes (Wegert et al. 2015) supports the role of dysregulated RNA 
turnover and stability in the aetiology of WT. This resonates well with our demonstration that 
WT1 interacts with 3’ UTR of RNA influencing stability, thus, arguing for a key regulatory 
role of WT1 RNA binding in the context of Wilms’ Tumour. 
 
Materials and Methods: 
RIP-seq: WT1 RIP-seq on endogenous WT1 in ES and M15 cells was done by formaldehyde 
crosslinking followed by sonication. DNase digested samples were immunoprecipitated with 
WT1 antibody. Interacting RNA was purified and processed for NGS. The data obtained was 
analyzed using pyCRAC. 
FLASH: UV crosslinked M15 cells were immunoprecipitated with WT1 conjugated agarose 
antibodies. The extracts were then treated with RNase and then formaldehyde crosslinked.  
The RNA protein complexes were purified after linker addition, were separated on a gel and 
transferred to a membrane. RNA was purified from the radioactive bands and processed for 
NGS analysis. Data analysis was done separately for the single reads and the hybrids 
obtained from FLASH.  
Transcriptome Analysis by RNA-seq: RNA from mouse ES cell line E14, Wt1 Knockout 
ES line (KO1A), M15 control, a stable lentiviral Wt1 knockdown M15 cell line, control lacZ 
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lentiviral stable line was isolated using the Qiagen RNeasy mini columns as per manufacturer 
protocol. The isolated total RNA (1 µg) was Poly A selected and subjected to library 
preparation with the NEBnext Ultra RNA library kit for Illumina sequencing. 
qRT-PCR validation: RNA was converted to cDNA and subjected to quantitative PCR 
using SyBR Green for detection. Gene expression data was analysed by  ΔΔCt method. The 
IP data was analysed for fold enrichment. Students’ unpaired t-test was used for statistical 
validations. 
Analysis of gene expression changes in wildtype and mutant tissues: Crosses were set up 
with the Wt1 floxed conditional with the Wt1-GFP knockin Nestin Cre line, E13.5 kidneys 
were single cell dissociated and FACS sorted using the GFP signal. RNA was isolated from 
FACS sorted control and mutant cells (identified by genotyping), using Trizol and followed 
by cDNA synthesis and qRT-PCR. 
Endogenous RNA stability assay: Actinomycin treated control and Wt1 knockdown cells 
were analyzed for gene expression at different time points. 
Luciferase Reporter Assay: WT1 interacting 3’ UTR binding fragments were analyzed for 
luciferase expression in a pIS1 based reporter assay in control and Wt1 knockdown cells. 
Footnotes: Detailed experimental procedures and data analysis is provided in Supplemental 
Information. 
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FIGURE LEGENDS: 
Figure 1: WT1 binds to multiple categories of RNA: (A) Pie charts of clusters assigned to 
protein-coding, noncoding and other biotypes in ES (top left), M15 (bottom left) and the 
proportion of noncoding RNAs in ES (top right), M15 (bottom right). (B) The density of 
clusters identified by RIP-seq, ES (top), M15 (bottom), for all protein coding RNAs (blue 
bars), and the density at 5’ and 3’ ends (green and red bars respectively). (C) Genome 
Browser snapshot of alignment of RIP-seq reads from ES and M15 cell lines mapping to 
Igfbp5. (D) Validation of WT1 interacting protein-coding RNA biotype. Igfbp5, Igfbp3, Pdgf, 
Peg3, Wnt5a, Wt1, Podxl Interaction was confirmed by RIP in M15 cell line analyzed by 
qRT-PCR with target-specific primers. 
 
Figure 2: UV crosslinking confirms WT1 enrichment over 3’ UTR of mRNAs: (A) 
Schematic of FLASH protocol. (B) Pie charts showing the proportion of clusters of protein-
coding, noncoding and other biotypes (top); noncoding RNAs (bottom) in the FLASH data. 
(C) The density of clusters identified in WT1 FLASH for protein coding (blue bars), and the 
density at 5’ and 3’ ends (green and red bars respectively). (D) REVIGO plot of p value based 
gene ontology terms, associated with WT1 interacting RNA, identified by FLASH.  
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Figure 3: WT1 associates with RNA at the 3’ UTR through secondary structures: (A) 
Pie-charts of WT1 FLASH associated hybrids (top), compared to input (bottom) in M15 cells 
analyzed as energy maps. (B) Local hybridization in 3’UTR regions for representative targets 
Igfbp5 and Cdh11. (C) RNA fold predictions of secondary structures of Podxl and Wt1 3’ 
UTR interactions. (D) Heat map representation of 3’ UTR intramolecular interactions in 
Podxl RNA identified by FLASH and PARIS. 
Figure 4: WT1 regulates the expression of a subset of the RNA binding targets: (A) 
Volcano plot of transcriptome changes of E14 and Wt1 Knockout ES cell lines (left, n=2) and 
the Wt1 stable knockdown in M15 cell line compared to the lacZ controls (right, n=2). X-axis 
is log2 fold change, y-axis is log10 p value. Selected genes are highlighted. (B) REVIGO plot 
of gene ontology analysis based on p values of the differentially regulated genes in ES (left) 
and M15 (right) upon Wt1 knockout/knockdown respectively. (C) WT1 interacting and 
regulated targets were validated by qRT-PCR. RNA changes in ES cells (Panel I); M15 cells 
(Panel II) compared between the knockout/knockdown and control. Log2 fold changes 
observed in RNA-seq (n=2) and qRT-PCR (n=3) are represented in blue and red bars 
respectively (unpaired t test, *** p<0.0001, ** p<0.001 * p<0.01). (D) RNA changes in GFP+ 
FACS sorted E13.5 kidney cells compared to litter matched cre control. (n=3).  
Figure 5: WT1 regulates RNA stability: (A) Scatterplots of log of the ratio of WT1 RIP-seq 
RPKM values to input (y axis) compared to the log of the ratio of coverage of genome wide (x 
axis); 3’ UTR (grey symbols), upregulated genes (green), downregulated genes (red) (ES, top; 
M15, bottom). (B) Relative percentage expression (y axis) of genes post actinomycin treatment 
in hours (x axis) compared between knockout/knockdown and control cells. (C) Luciferase 
reporter activity of WT1 interacting UTR binding regions transfected in knockdown cells 
compared to control. Vector alone transfections represent background luciferase activity 
without binding regions. (D) A working model for WT1 RNA interaction and its functional 
significance. 
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